ask="2.87"
ask_size="5000"
average_daily_volume="1046690"
bid="2.70"
bid_size="400"
book_value="0.34"
change="-0.13"
change_from_200_day_moving_average="1.05"
change_from_50_day_moving_average="0.78"
change_from_52_week_high="-1.35"
change_From_52_week_low="1.67"
change_in_percent="-4.47%"
close="2.78"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.23"
eps_estimate_next_quarter="-0.34"
eps_estimate_next_year="0.95"
ex_dividend_date="N/A"
float_shares="4441000"
high="2.88"
high_52_weeks="4.13"
last_trade_date="3/7/2017"
last_trade_price="2.78"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.71"
low_52_weeks="1.11"
market_capitalization="26.65M"
moving_average_200_day="1.73"
moving_average_50_day="2.00"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.00"
open="2.87"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+60.65%"
percent_change_from_50_day_moving_average="+38.91%"
percent_change_from_52_week_high="-32.69%"
percent_change_from_52_week_low="+150.45%"
previous_close="2.91"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="2.93"
price_per_book="8.58"
price_per_sales="54.81"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="1.02"
stock_exchange="NCM"
symbol="EYEG"
volume="885957"
weeks_range_52="1.11 - 4.13"
